Hostname: page-component-586b7cd67f-rcrh6 Total loading time: 0 Render date: 2024-11-28T17:27:07.807Z Has data issue: false hasContentIssue false
  • English
  • Français

Tryptophan disposition in psychiatric patients before and after stress

Published online by Cambridge University Press:  09 July 2009

G. Curzon ,
B. D. Kantamaneni ,
M. H. Lader  and
M. H. Greenwood
G. Curzon*
Affiliation:
Department of Neurochemistry, Institute of Neurology, London, and The Department of Psychiatry, Institute of Psychiatry, London
B. D. Kantamaneni
Affiliation:
Department of Neurochemistry, Institute of Neurology, London, and The Department of Psychiatry, Institute of Psychiatry, London
M. H. Lader
Affiliation:
Department of Neurochemistry, Institute of Neurology, London, and The Department of Psychiatry, Institute of Psychiatry, London
M. H. Greenwood
Affiliation:
Department of Neurochemistry, Institute of Neurology, London, and The Department of Psychiatry, Institute of Psychiatry, London
*
1Address for correspondence: Professor G. Curzon, Department of Neurochemistry, Institute of Neurology, 33 John's Mews, London WC1N 2NS.
Get access Rights & Permissions [Opens in a new window]

Synopsis

Non-esterified fatty acid and total and free tryptophan were determined in the plasma of psychiatric patients unselected with respect to psychiatric diagnosis and in the plasma of normal subjects before and after physiological and psychiatric tests. Retarded patients had significantly low total and free tryptophan values which correlated negatively with agitation. Total tryptophan fell significantly after testing in the non-retarded subjects. The only biochemical abnormality significantly associated with a diagnosis of primary depression was the rise of plasma non-esterified fatty acid after testing. Thus, tryptophan abnormalities were associated more with psychiatric rating scores than with diagnoses.

Type
Research Article
Information
Psychological Medicine , Volume 9 , Issue 3 , August 1979 , pp. 457 - 463
Copyright
Copyright © Cambridge University Press 1979

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

A˚sberg, M., Traskman, L. & Thoren, P. (1976). 5HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Archives of General Psychiatry 33, 1193–1197.CrossRefGoogle ScholarPubMed
Ashcroft, G. W., Crawford, T. B. B., Eccleston, D., Sharman, D. F., MacDougall, E. J., Stanton, J. B. & Binns, J. F. (1966). 5-Hydroxyindole compounds in the cerebrospinal fluid of patients with psychiatric or neurological disease. Lancet ii, 1049–1052.Google Scholar
Ashcroft, G. W., Blackburn, I. M., Eccleston, D., Glen, A. I. M., Hartley, W., Kinloch, N. E., Loneragan, M., Murray, L. G. & Pullar, I. A. (1973). Changes on recovery in the concentrations of tryptophan and the biogenic amine metabolites in the cerebrospinal fluid of patients with affective illness. Psychological Medicine 3, 319–325.Google Scholar
Banki, C. M. (1977). Correlation of anxiety and related symptoms with cerebrospinal fluid 5-hydroxyindoleacetic acid in depressed women. Journal of Neural Transmission 41, 135–143.Google Scholar
Bloxam, D. L. & Curzon, G. (1978). A study of proposed determinants of brain tryptophan concentration in rats after portocaval anastomosis or sham operation. Journal of Neurochemistry 31, 1255–1263.Google Scholar
Bond, A. J., James, D. C. & Lader, M. H. (1974). Physiological and psychological measures in anxious patients. Psychological Medicine 4, 354–373.Google Scholar
Bridges, P. K., Bartlett, J. R., Sepping, P., Kantamaneni, B. D. & Curzon, G. (1976). Precursors and metabolites of 5-hydroxytryptamine and dopamine in the ventricular cerebrospinal fluid of psychiatric patients. Psychological Medicine 6, 399–405.Google Scholar
Coppen, A., Shaw, D. M., Herzberg, B. & Maggs, R. (1967). Tryptophan in the treatment of depression. Lancet ii, 1178–1180.CrossRefGoogle Scholar
Coppen, A., Prange, A. J., Whybrow, P. C. & Noguera, R. (1972). Abnormalities of indoleamines in affective disorders. Archives of General Psychiatry 26, 474–478.CrossRefGoogle ScholarPubMed
Coppen, A., Eccleston, E. G. & Peet, M. (1973). Total and free tryptophan concentration in the plasma of depressive patients. Lancet ii 60–63Google Scholar
Curzon, G. & Greenwood, M. H. (1974). Plasma protein binding: free and bound tryptophan. Proceedings of the 9th Congress C.I.N.P.Excerpta Medica International Congress Series 349, 108–116.Google Scholar
Curzon, G. & Knott, P. J. (1975). Rapid effects of environmental disturbance on rat plasma unesterifled fatty acids and tryptophan concentrations and their prevention by antilipolytic drugs. British Journal of Pharmacology 54, 389–396.CrossRefGoogle Scholar
Curzon, G., Friedel, J., Kantamaneni, B. D., Greenwood, M. H. & Lader, M. H. (1974). Unesterified fatty acids and the binding of tryptophan in human plasma. Clinical Science 47, 415–424.CrossRefGoogle ScholarPubMed
Curzon, G., Kantamaneni, B. D., Van Boxel, P., Gillman, P. K., Bartlett, J. R. & Bridges, P. K. (1979). Substances related to 5-hydroxytryptamine in plasma and in lumbar and ventricular fluids of psychiatric patients. Acta Psychiatrica Scandinavica (in the press).Google Scholar
Denckla, W. D. & Dewey, H. K. (1967). The determination of tryptophan in plasma, liver and urine. Journal of Laboratory and Clinical Chemistry 69, 160–169.Google Scholar
Faires, R. A. & Parkes, B. H. (1960). Radioisotope Laboratory Techniques (2nd edn), p. 165. Newnes: London.Google Scholar
Gentil, V., Lader, M. H., Kantamaneni, B. D. & Curzon, G. (1977). Effects of adrenaline injection on human plasma tryptophan and non-esterifled fatty acids. Clinical Science 53, 227–232.CrossRefGoogle Scholar
Green, A. R., Woods, A. F., Knott, P. J. & Curzon, G. (1975). Factors influencing effect of hydrocortisonc on rat brain tryptophan metabolism. Nature 255, 170.Google Scholar
Hamilton, M. (1960). A rating scale for depression. Journal of Neurology. Neurosurgery and Psychiatry 23, 56–62.Google Scholar
Herrington, R. N., Bruce, A., Johnstone, E. C. & Lader, M. H. (1976). Comparative trial of L-tryptophan and amitryptyline in depressive illness. Psychological Medicine 6 673–678Google Scholar
Knott, P. J. & Curzon, G. (1972). Free tryptophan in plasma and brain tryptophan metabolism. Nature 239. 425–453.CrossRefGoogle ScholarPubMed
Knott, P. J., Hutson, P. H. & Curzon, G. (1977). Fatty acid and tryptophan changes on disturbing groups of rats and caging them singly. Pharmacology, Biochemistry and Behaviour 7, 245–252.CrossRefGoogle ScholarPubMed
Laurell, S. & Tibbling, G. (1967). Colorimetric micro-determination of free fatty acids in plasma. Clinica Chimica Acta 16, 57–62.CrossRefGoogle ScholarPubMed
Mason, J. W. (1968). A review of psychoendocrine research on the pituitary-adrenal cortical system. Psychosomatic Medicine 30, 576–607.CrossRefGoogle ScholarPubMed
Moller, S. E., Kirk, L. & Fremming, K. H. (1976). Plasma amino acids as an index for sub-groups in manic depressive psychosis: correlation to effect of tryptophan. Psychopharmacology 49, 205–213.CrossRefGoogle Scholar
Muller, W. E. & Wollert, U. (1975). Benzodiazepines; specific competitors for the binding of L-tryptophan to human serum albumin. Naunyn-Schmiedebergs Archiv für Pharmacologie 288, 17–27.CrossRefGoogle ScholarPubMed
Niskanen, P., Huttunen, M., Tamminen, T. & Jaaskelainen, J. (1976). The daily rhythm of plasma tryptophan and tyrosine in depression. British Journal of Psychiatry 128, 67–73.CrossRefGoogle ScholarPubMed
Noble, P. & Lader, M. (1971). Salivary secretion and depressive illness: a physiological and psychometric study. Psychological Medicine 1, 372–376.CrossRefGoogle ScholarPubMed
Riley, G. J. & Shaw, D. M. (1976). Total and non-bound tryptophan in unipolar disease Lancet ii 1249Google Scholar
Stein, G., Milton, F., Bebbington, P., Wood, K. & Coppen, A. (1976). Relationship between mood disturbances and free and total plasma tryptophan in post-partum women. British Medical Journal ii 457Google Scholar
Van Praag, H. M. & Korf, J. 1974 Serotonin metabolism in depression: clinical application of the probenecid test. International Pharmacopsychiatry 9, 35–51.Google Scholar
Van Praag, H. M., Korf, J., Lakke, J. P. W. F. & Schut, T. 1975 Dopamine metabolism in depressions, psychoses and Parkinson's disease: the problem of the specificity of biological variables in behaviour disorders. Psychological Medicine, 5 138–146.CrossRefGoogle Scholar
Wirz-Justice, A., Pühringer, W., Hole, G. & Menzi, R. (1975). Monoamine oxidase and free tryptophan in human plasma: normal variations and their implications for biochemical research in affective disorders. Pharmakopsychiatrie Neuro-Psychopharmakologie 8, 310–317.Google Scholar